<HTML>
<HEAD>
<TITLE>MedicaLogic/Medscape 8K, 1/25/02
</title>
</HEAD>
<BODY>

<!-- MARKER FORMAT-SHEET="Page Width Begin Rule" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD><HR SIZE=5 NOSHADE>
<BR>


<!-- MARKER FORMAT-SHEET="Reg Cover SEC Line 1 12pt" -->
<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=3><B>SECURITIES
AND EXCHANGE COMMISSION </B> </FONT><BR>

<!-- MARKER FORMAT-SHEET="Reg Cover SEC Line 2 10pt" -->
<FONT FACE="Times New Roman, Times, Serif" SIZE=1><B>WASHINGTON, D.C. 20549 </B> </FONT></P>


<HR SIZE=1 NOSHADE WIDTH=15% ALIGN=CENTER>

<!-- MARKER FORMAT-SHEET="Reg Cover Form Name" -->
<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=3><B>FORM 8-K </B></FONT></P>


<!-- MARKER FORMAT-SHEET="Head Major 10" -->
<H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>CURRENT REPORT<BR>
PURSUANT TO SECTION 13 OR 15(d) OF THE<BR>SECURITIES EXCHANGE ACT OF 1934 </FONT></H1>



<!-- MARKER FORMAT-SHEET="Head Major 10" -->
<H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Date of Report (Date
of earliest event reported) &nbsp;&nbsp;January 24, 2002 </FONT></H1>


<!-- MARKER FORMAT-SHEET="Reg Cover Company Name" -->
<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=4><B>MedicaLogic/Medscape,
Inc.</B> </FONT><BR>

<!-- MARKER FORMAT-SHEET="Reg Cover Description" -->
<FONT FACE="Times New Roman, Times, Serif" SIZE=2>(Exact name of registrant as
specified in charter) </FONT></P>

<!-- MARKER FORMAT-SHEET="Page Width End" -->
</TD>
</TR>
</TABLE>
<BR>


<!-- MARKER FORMAT-SHEET="Reg Cover Table 3 Col 10" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD ALIGN=CENTER WIDTH=33%><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"><B>Oregon</B>
     <BR>(State or other jurisdiction of<BR>incorporation) </FONT> </FONT></TD>
<TD ALIGN=CENTER WIDTH=34%><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"><B>000-28285</B>
     <BR>(Commission file number) </FONT> </FONT></TD>
<TD ALIGN=CENTER WIDTH=33%><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"><B>93-0890696</B>
     <BR>(IRS employer<BR>identification no.) </FONT> </FONT></TD>
</TR>
</TABLE>
<BR>


<!-- MARKER FORMAT-SHEET="Page Width Begin" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD>


<!-- MARKER FORMAT-SHEET="Para Center 10" -->
<P ALIGN=CENTER><FONT FACE="TIMES NEW ROMAN, TIMES, SERIF"><FONT SIZE="2"><B>20500 NW Evergreen
Parkway<BR>Hillsboro, Oregon 97124</B><BR>(Address of principal executive offices) </FONT> </FONT> </P>


<!-- MARKER FORMAT-SHEET="Para Center 10" -->
<P ALIGN=CENTER><FONT FACE="TIMES NEW ROMAN, TIMES, SERIF"><FONT SIZE="2"><B>(503) 531-7000</B>
<BR>Registrant&#146;s telephone number,<BR>including area code </FONT> </FONT> </P>


<!-- MARKER FORMAT-SHEET="Para Center 10" -->
<P ALIGN=CENTER><FONT FACE="TIMES NEW ROMAN, TIMES, SERIF"><FONT SIZE="2"><B>Not applicable</B><BR>(Former
name or former address, if changed since last report)</FONT></FONT> </P>


<!-- MARKER FORMAT-SHEET="Page Width End" -->
</TD>
</TR>
</TABLE>
<BR>

<PAGE>


<H2 ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Item 3.  Bankruptcy or Receivership</font></H2><br>

      <P>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On January 24, 2002 the Registrant and certain of its subsidiaries entered into an Asset Purchase Agreement (the "Asset Purchase
Agreement"), dated as of January 24, 2002, with GE Medical Systems Information Technologies, Inc. for the sale of substantially all
of Registrant's assets and the assumption of certain of its liabilities.  The purchase price under the Asset Purchase Agreement is
$20,000,000 in cash and the assumption of the assumed liabilities, subject to adjustment as set forth in the Asset Purchase
Agreement.  The Asset Purchase Agreement is subject to the approval of the Bankruptcy Court pursuant to Section 363 of the U.S.
Bankruptcy Code (as defined below).  This description of the terms of the Asset Purchase Agreement is not complete and is qualified
by reference to the Asset Purchase Agreement that is attached hereto as Exhibit 2.1 and incorporated herein by reference.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In connection with and contemporaneous with the execution and delivery of the Asset Purchase Agreement, Registrant and its five
United States subsidiaries filed a voluntary petition for bankruptcy protection under Chapter 11 of the U.S. Bankruptcy Code in the
United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court").  The case has been assigned to the Honorable
Judge Peter J. Walsh under case number 02-10253.  In addition to the Registrant, the filing entities were MedicaLogic Enterprises,
Inc., MSCP Holdings, Inc., MedicaLogic Pennsylvania, LLC, MedicaLogic of Texas, Inc. and MedicaLogic Texas, L.P.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A copy of the Registrant's joint press release, dated January 24, 2002 announcing the Asset Purchase Agreement and the filing is
attached as Exhibit 99.1 hereto and is incorporated herein by reference.</p>

<H2 ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Item 7.  Financial Statements and Exhibits</font></H2><br>



<i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)  Exhibits</i>


<H2 ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2><u>Exhibit No.</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;     <u>Description</u></FONT></H2>


         2.1             &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Asset Purchase Agreement<br>

         99.1           &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Press Release, dated January 24, 2002<br>



<H2 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>SIGNATURE</FONT></H2>

         <P>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

Date:  January 25, 2002<br><br><br>



&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MEDICALOGIC/MEDSCAPE, INC.<br><br><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By: <u>/s/ Donald A. Bloodworth</u><br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Donald A. Bloodworth<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Chief Financial Officer</i>

<br><br><BR><BR>





<H2 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>EXHIBIT INDEX</FONT></H2><br>


<u><b>Exhibit No.</b></u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u><b>Description</b></u><br><br>


        2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Asset Purchase Agreement, dated as of January 24, 2002, by and among
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MedicaLogic/Medscape, Inc., MSCP Holdings, Inc., <br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MedicaLogic Enterprises, Inc., MedicaLogic Pennsylvania, LLC, MedicaLogic of <br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Texas, Inc. and GE Medical Systems Information Technologies, Inc.<br><br>


       99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Press Release, dated January 24, 2002<br>






</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "medicalogic8k125.htm", "description": "TEXT OF 8K", "secsgml_size_bytes": 9861}]
{"company-data": {"conformed-name": "MEDICALOGIC/MEDSCAPE INC", "cik": "0000923899", "assigned-sic": "7374", "irs-number": "930890696", "state-of-incorporation": "OR", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-28285", "film-number": "02517764"}, "business-address": {"street1": "20500 NW EVERGREEN PARKWAY", "street2": "STE 400", "city": "HILLSBORO", "state": "OR", "zip": "97124", "phone": "5035317000"}, "mail-address": {"street1": "20500 NW EVERGREEN PARKWAY", "city": "HILLSBORO", "state": "OR", "zip": "97124"}, "former-company": {"former-conformed-name": "MEDICALOGIC INC", "date-changed": "19990818"}}
MedicaLogic/Medscape 8K, 1/25/02
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date
of earliest event reported)   January 24, 2002
MedicaLogic/Medscape,
Inc.
(Exact name of registrant as
specified in charter)
Oregon
(State or other jurisdiction of
incorporation)
000-28285
(Commission file number)
93-0890696
(IRS employer
identification no.)
20500 NW Evergreen
Parkway
Hillsboro, Oregon 97124
(Address of principal executive offices)
(503) 531-7000
Registrant's telephone number,
including area code
Not applicable
(Former
name or former address, if changed since last report)
Item 3.  Bankruptcy or Receivership
On January 24, 2002 the Registrant and certain of its subsidiaries entered into an Asset Purchase Agreement (the "Asset Purchase
Agreement"), dated as of January 24, 2002, with GE Medical Systems Information Technologies, Inc. for the sale of substantially all
of Registrant's assets and the assumption of certain of its liabilities.  The purchase price under the Asset Purchase Agreement is
$20,000,000 in cash and the assumption of the assumed liabilities, subject to adjustment as set forth in the Asset Purchase
Agreement.  The Asset Purchase Agreement is subject to the approval of the Bankruptcy Court pursuant to Section 363 of the U.S.
Bankruptcy Code (as defined below).  This description of the terms of the Asset Purchase Agreement is not complete and is qualified
by reference to the Asset Purchase Agreement that is attached hereto as Exhibit 2.1 and incorporated herein by reference.
In connection with and contemporaneous with the execution and delivery of the Asset Purchase Agreement, Registrant and its five
United States subsidiaries filed a voluntary petition for bankruptcy protection under Chapter 11 of the U.S. Bankruptcy Code in the
United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court").  The case has been assigned to the Honorable
Judge Peter J. Walsh under case number 02-10253.  In addition to the Registrant, the filing entities were MedicaLogic Enterprises,
Inc., MSCP Holdings, Inc., MedicaLogic Pennsylvania, LLC, MedicaLogic of Texas, Inc. and MedicaLogic Texas, L.P.
A copy of the Registrant's joint press release, dated January 24, 2002 announcing the Asset Purchase Agreement and the filing is
attached as Exhibit 99.1 hereto and is incorporated herein by reference.
Item 7.  Financial Statements and Exhibits
(c)  Exhibits
Exhibit No.
Description
2.1                                   Asset Purchase Agreement
99.1                               Press Release, dated January 24, 2002
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:  January 25, 2002
MEDICALOGIC/MEDSCAPE, INC.
By:
/s/ Donald A. Bloodworth
Donald A. Bloodworth
Chief Financial Officer
EXHIBIT INDEX
Exhibit No.
Description
2.1                         Asset Purchase Agreement, dated as of January 24, 2002, by and among
                              MedicaLogic/Medscape, Inc., MSCP Holdings, Inc.,
MedicaLogic Enterprises, Inc., MedicaLogic Pennsylvania, LLC, MedicaLogic of
Texas, Inc. and GE Medical Systems Information Technologies, Inc.
99.1                       Press Release, dated January 24, 2002